The National Institute on Drug Abuse (NIDA), part of the National Institutes of Health, today announced seven recipients of its two Avenir Award programs for HIV/AIDS and genetics or epigenetics research. The awards will support exciting approaches with tools such as genome editing and smart...
Image courtesy of ADAPT Pharma, Inc. Responding to public demand for tools and information to help stem the growing opioid overdose epidemic, the National Institute on Drug Abuse (NIDA) has created a web section dedicated to resources about the opioid overdose reversal drug naloxone. The new web...
Courtesy of Braeburn Pharmaceuticals The National Institute on Drug Abuse (NIDA), part of the National Institutes of Health, is pleased to announce that the U.S. Food and Drug Administration (FDA) has approved the first long-acting, subdermal buprenorphine implant for the treatment of opioid...
A project showing how negative attitudes about stress impact key factors that influence vulnerability to addiction, including sleep, emotion and cognition, won a first place Addiction Science Award at the 2016 Intel International Science and Engineering Fair (ISEF)—the world’s largest science...
NIDA hosts research track at APA annual meeting The National Institute on Drug Abuse (NIDA) will present a research track at the 2016 American Psychiatric Association’s (APA’s) Annual Meeting in Atlanta, GA from May 14th through 18th. The NIDA sessions will focus on high priority areas related to...
Dr. Nora Volkow, director of the National Institute on Drug Abuse, part of the National Institutes of Health, will speak about the addicted brain at X-STEM, an Extreme STEM Symposium for middle through high school students on April 14, 2016 in Washington, D.C. X-STEM is a “TED-style” event...
©istockphoto/kwanchaichaiudom New research funded by the National Institute on Drug Abuse (NIDA) revealed that the initial relapse rates among opioid-dependent adults in the criminal justice system was lower for participants receiving extended-release naltrexone than for those receiving treatment...
©Shutterstock/David Smart More than 30 percent of Americans have some form of chronic pain. Yet, the over-reliance on the millions of opioid pain reliever prescriptions dispensed yearly have resulted in a national epidemic of overdose deaths and addiction. A review article published today in The...
©istockphoto/wenht NIDA-funded research using brain scans shows that severe marijuana dependence (now referred to as cannabis use disorder) is associated with a reduced release of dopamine within the striatum, a region involved in working memory, impulsivity and attention. Lower dopamine release...
©iStock/AlexRaths New research funded by the National Institute on Drug Abuse revealed that of previously incarcerated youths, more than 90% of males and nearly 80% of females had a substance use disorder at some point in their lifetime. The longitudinal study randomly sampled 1,829 youth -- ages...